Skip to main content

Table 1 (abstract P220). Comparison of the 2 groups: esmolol (n=36) versus control group (n=113)

From: 39th International Symposium on Intensive Care and Emergency Medicine

  CONTROL GROUP ESMOLOL GROUP p VALUE
LENGTH OF STAY (DAYS) (m. ± SE) 4.1 ± 0.6 15 ± 3 < 0.001a d
NIHSS (7 DAYS) mean (range) 2 (0 - 28) 11 (0 - 25) < 0.001a d
COMPLICATIONNO (%)YES (%) 110 (97.3) 3 (2.7) 32 (88.9) 4 (11.1) 0.05c d
FUNCTIONAL OUTCOME(mRS ≤ 2) (%)(mRS > 2) (%) 80 (70.8) 33 (29.2) 16 (44.4) 20 (55.6) 0.004b d
SAPS II (n= 99) mean (range) 24 (6 - 59) 28 (13 - 61) 0.026a d
ATRIAL FIBRILLATIONNO (%)YES (%) 81 (71.7) 32 (28.3) 14 (38.9) 22 (61.1) < 0.001b d
  1. a:Mann-Whitney U test. b:x2 after Yates correction. c:Fisher¢s exact test. mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale, SAPS II: Simplified Acute Physiology Score II, d:Statistically significant